Answers are grounded in this paper and cite their sources.
Reveals how inflammatory and haemostatic pathways drive plaque rupture and cardiovascular risk, highlighting therapeutic potential in ischaemic heart disease.
Many molecular and cellular mechanisms link inflammation and haemostatic mechanisms. Inflammation, and perhaps chronic infection, may play important roles in the initiation and progression of atherosclerosis. Atherosclerotic lesions are heavily infiltrated by cellular components associated with inflammation (macrophages and T lymphocytes), and acute plaque rupture is also associated with inflammatory components. Several markers of systemic inflammation may predict future cardiovascular events in apparently healthy subjects as well as in patients with chronic and acute syndromes. There may thus be therapeutic potential in modifying the atherosclerotic, vasomotor, and thrombotic components of ischaemic heart disease.
No takes yet. Share an insight, caveat, or question.
D Tousoulis (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: